Evidence map›Paper›PMID 29725423›Full record

ArticleOncology letters2018

Role of a non-canonical splice variant of the

Yinghui Li, Yanhua Liu, Can Liu, Fengyong Liu, Daolei Dou, Wenjie Zheng, Wei Liu, Feifei Liu

Open access · diamondAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Oncology letters, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact, top 97% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 1 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 4 institutions in 1 country.

Yinghui LiDepartment of Immunology, School of Medicine, Nankai University, Tianjin 300071, P.R. China.
Yanhua LiuDepartment of Immunology, School of Medicine, Nankai University, Tianjin 300071, P.R. China.
Can LiuDepartment of Immunology, School of Medicine, Nankai University, Tianjin 300071, P.R. China.
Fengyong LiuDepartment of Pathophysiology, School of Basic Medical Sciences, Tianjin Medical University, Tianjin 300070, P.R. China.
Daolei DouDepartment of Experimental Facility, State Key Laboratory of Medical Chemical Biology, Tianjin 300071, P.R. China.
Wenjie ZhengTechnical Center for Safety of Industrial Products, Tianjin Entry-Exit Inspection and Quarantine Bureau, Tianjin 300308, P.R. China.
Wei LiuTechnical Center for Safety of Industrial Products, Tianjin Entry-Exit Inspection and Quarantine Bureau, Tianjin 300308, P.R. China.
Feifei LiuDepartment of Immunology, School of Medicine, Nankai University, Tianjin 300071, P.R. China.
Nankai University · CNShanghai Entry-Exit Inspection and Quarantine Bureau · CNState Key Laboratory of Chemical Engineering · CNTianjin Medical University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

T-cell acute lymphoblastic leukemia is a hematopoietic malignant disease, which arises from a genetic defect in the T-cell maturation signaling pathway. As a result, it is necessary to identify the molecules that impact T-cell development and control lymphoid-lineage malignancy. The present study utilized Jurkat T lymphoblastic cells as a well-established approach for the investigation into the function of the non-canonical alternative splice variant of Helios for the

Indexed as

HeliosIkarosT-cell leukemiatranscription factor

Identifiers

PMID29725423
PMCPMC5920270
OpenAlexW2791716777

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.